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ABSTRACT 
NEUROMODULATION FOR DEPRESSION: INSIGHTS GAINED FROM 
NEUROIMAGING AND COMPUTATIONAL MODELS 
 
Yagna Pathak, B.S., M.Eng. 
Marquette University, 2014 
 
 
 
Major depressive disorder (MDD) is a public health concern worldwide, affecting 
a sixth of the American population. Neuromodulation therapies have been employed to 
treat severe cases of treatment resistant depression. These procedures attempt to modulate 
activity in cortical regions that represent nodes in brain circuits believed to be involved in 
MDD. One challenge in neuromodulation trials has been the difficulty in quantifying 
outcome variability. We sought to understand the effects of neuromodulation therapies 
and their sources of variability while adding an objective perspective to assess clinical 
improvement in neuropsychiatric disorders such as depression.  
 
The goal of my dissertation was to investigate the neuronal circuitry of MDD 
patients who were treated using neuromodulation. Our primary measures were behavior 
scores and results from functional neuroimaging. The specific aims of this study were to 
answer three fundamental questions: 1) What is the role of stimulation parameters in 
patient response to chronic epidural cortical stimulation (EpCS) for MDD? 2) What 
functional changes result from repetitive transcranial magnetic stimulation (rTMS) for 
MDD? 3) How does stimulation of different targets in the depressive circuit affect 
antidepressive response? Our results suggest that combining neuroimaging with 
computational tools can increase the predictive power to determine who is likely to 
respond to a specific neuromodulation treatment course. We demonstrated the 
significance of stimulation parameters (location, polarity, duration) and the engagement 
of crucial nodes of the depressive circuit in order to achieve a sustained clinical 
improvement. Additionally, we showed that it is possible to affect deeper brain regions 
by targeting superficial areas that are easier to access with noninvasive modalities. The 
approaches highlighted in this dissertation can provide valuable insights about patients 
evaluated for neuromodulation for depression. 
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GLOSSARY 
 
 
 
AP   action potential 
BDNF   brain-derived neurotrophic factor 
CSF   cerebrospinal fluid 
CT   computed tomography 
Coherence  magnitude squared coherence 
DBS   deep brain stimulation 
DTI   diffusion tensor imaging 
ECT   electroconvulsive therapy 
EEG   electroencephalography 
EKG   electrocardiography 
EOG   electrooculography 
EpCS   chronic epidural cortical stimulation 
fMRI   functional magnetic resonance imaging 
HDRS   Hamilton depression rating scale 
IPG   implantable pulse generator 
L-DLPFC  left dorsolateral prefrontal cortex 
MADRS  Montgomery-Asberg depression rating scale 
MDD   major depressive disorder 
MEG   magnetoencephalography 
MRI   magnetic resonance imaging 
NAc   nucleus accumbens 
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OFC   orbitofrontal cortex 
pACC   pregenual anterior cingulate cortex 
PAG   periaqueductal gray area  
PET   positron emission tomography 
PFC   prefrontal cortex 
Pial surface  outermost layer of the cerebral cortex 
PSD   power spectral density 
ROI    region of interest 
RMT   resting motor threshold 
rTMS   repetitive transcranial magnetic stimulation 
sACC   subgenual anterior cingulate cortex 
VMPFC  ventromedial prefrontal cortex 
VNS   vagal nerve stimulation 
VT area  ventral tegmental area 
VTA   volume of tissue activation 
WMF   white matter fibers 
wMNE  weighted Minimum-Norm Estimate 
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SPECIFIC AIMS 
 
 
 
Nearly one-sixth of the American population is affected by depression over the 
course of their lifetime. Major depressive disorder MDD occurrence has increased, 
making it a leading cause of disability worldwide. Previous studies have focused on 
empirical observations of therapeutic effects without a detailed explanation of clinical 
improvement. Due to variable efficacy of pharmacological treatments, neuromodulation 
has emerged as a lucrative option. The goal of my doctoral work was to examine the 
neuronal circuitry involved in MDD by combining neuroimaging and computational 
tools. Through the studies outlined below, we established the ability of these translational 
techniques to increase the predictive power of a robust clinical response. The results and 
methods contribute to current knowledge by guiding the evaluation of patients treated 
with neuromodulation for depression.  
Specific Aim 1: What is the role of stimulation parameters in patient response to 
EpCS for MDD? 
Our hypothesis was that the degree of variability in patient response to EpCS can 
be attributed to the parameters of the stimulation protocol. Our results demonstrated that 
stimulation polarity, electrode location, and duration of stimulation are important factors 
in determining the effectiveness of this therapy.  
Specific Aim 2: What functional changes result from rTMS for MDD? 
In this study, we hypothesized that modulation of L-DLPFC can be assessed with 
resting-state functional imaging. We demonstrated changes in PSD and functional 
connectivity between important regions of the MDD circuit. Lastly, we also showed that 
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noninvasive approaches can be used to interrogate deeper brain areas and, consequently, 
guide future DBS studies. 
Specific Aim 3: How does stimulation of different targets in the depressive circuit 
affect antidepressive response? 
This aim was motivated by previous reports of variable outcomes of DBS for 
depression. Our hypothesis for this aim was that improvement in depressive behavior 
would be dependent on stimulation within the MDD circuit and at a particular target. Our 
results confirmed the differential involvement of different nodes in MDD pathology 
while emphasizing the need to continue our investigation in this field with the perspective 
of circuit-based therapeutic options for MDD.   
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CHAPTER 1: BACKGROUND/SIGNIFICANCE 
 
 
 
I. Major Depressive Disorder  
A. General Impact and Neurobiology 
MDD affects approximately 14 million Americans every year (Lisanby, 2007). 
According to the World Health Organization, it will be the second most common cause of 
disability by the year 2020. It impairs the patient’s quality of life and can lead to death by 
suicide. It is characterized by depressed mood, anhedonia, irritability, poor concentration, 
feelings of hopelessness, thoughts of self-harm, inappropriate guilt, and abnormal 
appetite and sleep patterns (Kopell et al., 2011; Krishnan & Nestler, 2008; Mayberg, 
1997). The rate of response to antidepressant medications is as low as 50%. According to 
the STAR*D trial (Rush et al., 2006), the remission rate decreases as treatment steps 
(number of medications) increase. Because of its significant impact on the general 
population and lost productivity, it is important to better understand the causes and 
underlying mechanisms of MDD.  
MDD is clinically heterogeneous. The diagnosis and assessment for improvement 
are also subjective (Krishnan & Nestler, 2008). No clinically suitable methods have been 
developed to predict treatment response (Ramasubbu & MacQueen, 2010). In addition, 
several models have been proposed, but with limited data to validate those findings or use 
them for effective therapy options.  
 MDD is a circuit-based disorder with several regions of the brain (prefrontal 
cortex (PFC), amygdala, striatum, pallidum, and medial thalamus) functionally aberrant 
(Drevets et al., 1992). Activity in the limbic regions, specifically the amygdala and 
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anterior cingulate cortex (ACC) (Brodmann’s area 25), is associated with depressive 
symptoms. Several hypotheses have been proposed to characterize MDD. The 
monoamine hypothesis (Krishnan & Nestler, 2008; Pittenger & Duman, 2008) suggests 
that a decrease in monoamine function can lead to depression. Among the monoamine 
projections from mid-brain to brainstem nuclei are 1) dopamine from the ventral 
tegmental area (VT area), 2) serotonin from dorsal raphe in the periaqueductal gray area 
(PAG), and 3) noradrenaline from locus coerulus. Secondary neuroplasticity on a cellular 
level is also induced by some antidepressants that acutely increase synaptic monoamines. 
In addition, the brain-derived neurotrophic factor (BDNF) hypothesis (Krishnan & 
Nestler, 2008; Nestler & Carlezon, 2006; Pittenger & Duman, 2008) implies that an 
increase in BDNF at the VT area and nucleus accumbens (NAc) may increase 
neurovegetative symptoms associated with depression.  
B. Key Regions 
Abnormalities in the cortico-limbic structure and function are commonly 
identified in MDD (Mayberg, 2003; Ramasubbu & MacQueen, 2010). For noninvasive 
and minimally invasive methods of neuromodulation, the immediate target must be 
superficial for easy access. The left dorsolateral prefrontal cortex (L-DLPFC), which is 
hypometabolic (Koenigs & Grafman, 2009; Mayberg, 2003) in MDD, tends to be an 
effective target for rTMS and EpCS. For more invasive techniques such as DBS, the 
subgenual anterior cingulate cortex (Hamani et al., 2009; Ressler & Mayberg, 2007) 
(sACC), amygdala, and NAc (Bewernick et al., 2010, 2012) are common targets and tend 
to be hypermetabolic (Figure 1).  
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Figure 1.1: Key regions that are affected in the depressive circuit (Adapted from Krishnan 2008) 
 
 
 
L-DLPFC: The role of L-DLPFC in neuropsychological disorders has been 
investigated extensively. DLPFC is implicated in cognitive and executive function, 
receives input from specific sensory cortices, and has interconnections with premotor 
areas, frontal eye fields, and the lateral parietal cortex (Koenigs & Grafman, 2009). 
Morphological changes associated with depression include decreased cortical thickness, 
decreased neuronal and glial densities, and decreased neuronal size (Miller & Cummings, 
2007; Rajkowska et al., 1999). The role of the PFC in depression is demonstrated in the 
literature through imaging and lesion studies. A region-of-interest (ROI) analysis 
revealed that connectivity between the dorsal cingulate cortex and three other regions 
(medial thalamus, amygdala, and pallidostriatum) was reduced in depressed patients 
when compared with controls (Anand et al., 2005a; Ramasubbu & MacQueen, 2010). 
One recent resting-state functional magnetic resonance imaging (fMRI) study (Fox, 
Buckner, et al., 2012) showed that better clinical efficacy was found when L-DLPFC 
coordinates were negatively correlated with the sACC. This study further suggests that 
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part of the antidepressant mechanism of noninvasive neuromodulation involves altering 
activity at distal nodes such as the sACC, which plays a significant role in MDD.  
sACC: The relevance of sACC in depression has been reported consistently. 
Anatomically, a decrease in glial density at this region has been associated with 
depression (Cotter et al., 2001; Miller & Cummings, 2007; Ongur et al., 1998). Activity 
in sACC couples with activity in the medial thalamus, thereby contributing to limbic-
cortical dysregulation (Greicius et al., 2007; Mayberg, 1997). In one study, the length of 
a depressive episode correlated positively with functional connectivity in sACC (Greicius 
et al., 2007). The sACC is implicated in emotional and affective functions; it has 
projections to ventral striatum to modulate the reward and motivation circuit (Johansen-
Berg et al., 2008; Koenigs & Grafman, 2009) and to PAG, hypothalamus, NAc, and 
amygdala to regulate visceral activity associated with emotion (Banks et al., 2007; 
Koenigs & Grafman, 2009). 
Amygdala: Amygdala plays a major role in emotional regulation and memory 
formation (Canli et al., 2000; Drevets, 2001; Le Doux, 1996; Phelps et al., 1997). This 
region is typically hypermetabolic in depression. Increased blood flow at the amygdala 
has been observed in depression and during presentation of negative stimuli (Drevets, 
2001; Drevets et al., 1992).  Additionally, electrical stimulation of this area can evoke 
emotional memories (Brothers et al., 1990; Gloor et al., 1982). Structural asymmetry of 
this region has been documented for psychiatric conditions (Lu et al., 2013; Monkul et 
al., 2007; Morris et al., 1998). Norepinephrine released at the amygdala is a critical 
player in emotional learning and is elevated in depressed individuals (Drevets, 2001; 
Veith et al., 1994) Previous studies have also demonstrated coupling between amygdala 
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and both the DLPFC and sACC during negative affect (Banks et al., 2007; Drevets, 
2001). The PFC has an inhibitory effect at this site in a top-down manner (Quirk & Beer, 
2006). Fibers projecting from the PFC terminate on the inhibitory interneurons of the 
amygdala (Carmichael & Price, 1995; McDonald et al., 1996). Furthermore, the 
amygdala shares reciprocal anatomical connections with the ACC, orbitofrontal cortex 
(OFC), and dorsal medial prefrontal cortex (DMPFC) (Amaral & Price, 1984; Banks et 
al., 2007; Ghashghaei et al., 2007). Lastly, a recent MEG study showed an increased 
connectivity between the ACC and left amygdala in high frequency bands (Lu et al., 
2013).  
NAc: Anhedonia is a major symptom of severe depression and, therefore, NAc, 
which is a critical component of the reward circuit and a motivational link between the 
limbic and motor regions, has been investigated as a potential target for neuromodulation 
therapy (Krishnan & Nestler, 2008; Schlaepfer et al., 2008). Neuroimaging studies show 
increases in neuron activity at the NAc and increases in dopamine release in response to 
euphoric experiences. In the context of limbic regulation, a recent animal study 
demonstrated a dysfunctional reward system in mice exposed to social defeat stress that 
was then reversed by administering antidepressants (Berton et al., 2006; Schlaepfer et al., 
2008). Anatomically, NAc has reciprocal connections with amygdala and the medial 
PFC. In addition, it receives projections from dopaminergic regions such as the VT area, 
OFC, and motor areas (dorsal caudate and globus pallidus). It also indirectly projects to 
the sACC, ventral pallidum, thalamus, and hypothalamus (Jones & Mogenson, 1980; 
Kelley & Stinus, 1984; Mogenson et al., 1983; Nauta & Domesick, 1984). Several of 
these regions are also implicated in depression. In a preliminary study investigating DBS 
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at this target, clinical improvement was observed following stimulation, which was 
further reflected through metabolic changes at specific sites measured with PET 
(Schlaepfer et al., 2008).  
 
II. Neuromodulation for Depression 
The current gold standard in neuromodulation treatment for MDD is 
electroconvulsive therapy (ECT) (Carpenter et al., 2009). However, sustained response is 
difficult and ECT efficacy varies with remission rates reported within the range of 20-
80% (Carpenter et al., 2009; Sackeim, 2001). Also, this therapy is accompanied by an 
array of side effects including anterograde and retrograde amnesia, headaches, muscle 
aches, nausea, and fatigue (Carpenter et al., 2009; Fujita et al., 2006; Moscrip et al., 
2006). As a result, there is a need for safer and more reliable interventions. Thus, 
neuromodulation techniques such as vagal nerve stimulation (VNS), chronic epidural 
stimulation (EpCS), repetitive transcranial magnetic stimulation (rTMS), and deep brain 
stimulation (DBS) are being investigated as treatment options. 
A. Chronic Epidural Cortical Stimulation (EpCS) 
EpCS is a minimally invasive method of cortical stimulation in which electrodes 
are implanted between the dura mater and the skull over the ROI for therapeutic benefits. 
Effects of EpCS depend on stimulation parameters such as electrode location, frequency, 
amplitude, pulse width, duty cycle, and polarity (Lefaucheur, 2008; Ranck, 1975). This 
method of stimulation targets pyramidal neurons located in the superficial layers of the 
cortex (Manola et al., 2005, 2007). Because each stimulation parameter has a specific 
effect, a combination of settings can be employed to initiate a cascade that will affect 
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both proximal and distal neural elements. Stimulation location and polarity are influential 
variables in achieving a specific circuit-level result. For example, a cathode preferentially 
hyperpolarizes neurons parallel to the electrode surface whereas an anode depolarizes 
neurons perpendicular to it (Lefaucheur, 2008; McIntyre & Grill, 1999). 
B. Repetitive Transcranial Magnetic Stimulation (rTMS) 
TMS is a noninvasive neurostimulation method to modulate the brain. The first 
TMS device to stimulate the cortex was designed by Barker and Cain in 1985 (Barker et 
al., 1985). Since then, the device has evolved with a plethora of stimulation parameters 
and coil geometries to target a specific region of the brain. It works through the principle 
of induction as described by Faraday. A magnetic field, generated by the current in the 
TMS coil, induces an electrical field in the underlying cerebral cortex, which causes local 
depolarization of pyramidal neurons (Figure 2) (Carpenter et al., 2009; Cohen et al., 
1991; Ridding & Rothwell, 2007; Roth et al., 1991). This method can be viewed as 
introducing noise into the neural system. It is an attractive method because of its potential 
for high spatial and temporal resolution (Walsh & Cowey, 2000). However, the field 
declines logarithmically with optimal depth of depolarization at 2 cm with the figure-8 
coil (George et al., 1999). Therefore, superficial structures make better targets for TMS 
therapy.  
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Figure 1.2: Physics of TMS. This figure was reprinted with permission from Ridding et al. Nature Reviews 
Neuroscience (2007) 
 
 
 
Neuronal activity can be altered directly beneath the coil and at distant areas by 
mediating functional connections of these networks (Walsh & Cowey, 2000). A series of 
pulses is referred to as a train and application of these trains is defined as repetitive TMS 
(rTMS). Studies have investigated rTMS as both a priming method and a treatment 
option for depression (Fitzgerald et al., 2008, 2009). Location of stimulation and intensity 
are important parameters in rTMS therapy. Slow rTMS (< 1 Hz) has shown to be 
inhibitory whereas fast rTMS (> 5 Hz) is excitatory (Burt et al., 2002; Chen et al., 1997; 
Lefaucheur, 2008; Nakamura et al., 1997). Typically, the field strength is around 1.5 T 
for biphasic pulses and stimulation is applied at 10 Hz with a 5-second ‘ON’ period 
(Demitrack, 2007; Fitzgerald et al., 2009; O’Reardon et al., 2007) at the L-DLPFC 
(Nahas et al., 2001; Pascual-Leone et al., 1999). The intensity of stimulation depends on 
the individual’s resting motor threshold (RMT), which can be measured by stimulation at 
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the hand-knob region of the motor cortex. Efficacy has been reported with rTMS applied 
in the range of 80-120% of RMT. The specific mechanisms of action are still unclear; 
however, an increase in BDNF has been reported poststimulation in both animal and 
human studies (Muller et al., 2000; Shimizu et al., 2003).  
C. Deep Brain Stimulation (DBS) 
DBS has been instrumental in shaping the field of neuromodulation for psychiatry 
and adding to our understanding of neurological disorders. The success of DBS for 
movement disorders, specifically Parkinson’s disease, is a milestone in the field of 
functional neurosurgery. Many of these success stories have also reported improvement 
in affective symptoms, which has led to an extensive investigation of appropriate targets 
for neuropsychiatric disorders. DBS is the most invasive of the methods we focused on in 
this dissertation. It combines medical imaging (MRI + CT), neuronavigation, and 
physiological mapping to ensure correct placement of the electrode within the brain. 
During the procedure, the patient is awake but sedated (Greenberg, 2009). For specific 
disorders, appropriate targets have been explored based on results of lesion studies and 
advances in functional neuroimaging. The sACC and NAc of the striatum have been 
popular candidates for DBS for depression (Hamani et al., 2009; Malone et al., 2009; 
Mayberg et al., 2005; Riva-Posse et al., 2014).  
The specific mechanisms of action for DBS remain open for debate. Many studies 
report contradictory effects, suggesting a combination of inhibitory and excitatory 
mechanisms to recruit cell bodies and axons depending mostly on the orientation of 
neural elements relative to electrode location. Other hypotheses have hinted at an 
inhibitory effect of high frequency DBS by activating GABAergic terminals or blocking 
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voltage-gated ion channels (Benabid et al., 2005; Greenberg, 2009). Simplistically, DBS 
has also been described as a functional lesion that modifies neurotransmission by 
implicating synaptic fatigue (Benabid et al., 2005; Rauch et al., 2006).  
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CHAPTER 2: GENERALIZED EXPERIMENTAL METHODS 
 
 
I. Neuroimaging 
Cognitive processing is an underlying function of networks that connect the major brain 
regions, and neuroimaging can be combined with neuromodulation to further extract 
information about local responses and remote interactions (Siebner et al., 2009; Thut & 
Pascual-Leone, 2010). Multimodal imaging offers improved prediction of outcomes and a 
better understanding of the brain state throughout treatment. Studying neuromodulation 
with multimodal neuroimaging is especially useful for exploring the temporospatial 
dynamics within functional brain networks (Siebner et al., 2009). Each imaging modality 
operates according to distinct theories and can provide unique insights. For example, both 
electroencephalography (EEG) and magnetoencephalography (MEG) sensors are 
differentially sensitive to the dipole moments that radiate from the brain; EEG sensors are 
sensitive to normal dipole moments whereas MEG sensors are sensitive to tangent dipole 
moments (Baillet et al., 2001; Nunez & Silberstein, 2000; Papanicolaou, 2009). Using 
these modalities along with structural and diffusion MRI can enhance our understanding 
of regions involved in MDD in the context of the depressive circuit.  
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Figure 2.1: Origin of magnetic signals for MEG. Magnetic (B) fields are perpendicular to current flow 
making MEG sensors more sensitive to current in the sulcus than the gyrus.  
 
 
  
II. Functional Connectivity 
A thorough analysis of the functional role of distinct regions of the brain and their 
interactions is necessary to add details to the network model of MDD. Therefore, it is 
important to understand the concepts of functional segregation (activation of a particular 
brain area) and functional integration (synchronized stimulation of distant neural 
networks). Stemming from these concepts are the measures (Sakkalis, 2011; Schoffelen 
& Gross, 2009) of functional connectivity and effective connectivity. Functional 
connectivity (FC) is defined as temporal correlation of spatially distributed cortical 
regions. Effective connectivity (EC) is defined as the direct or indirect influence of one 
neural assembly on another, which describes directional interactions. 
For the purpose of this study, we focus on linear measures of FC. We use the 
methods of magnitude-squared coherence (coherence), which is the cross-spectral density 
function of two signals, or wavelet coherence, which requires a priori information to 
determine time-frequency resolution. Coherence is sensitive to power and phase and 
measures relationship stability; whereas correlation is sensitive to polarity and phase, but 
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not amplitude. These measures of connectivity are essentially signal processing 
algorithms and assume stationarity. For increased accuracy, connectivity should be 
determined by integrating neuroanatomical information from DTI and high temporal 
resolution approaches (Sakkalis, 2011; Schoffelen & Gross, 2009). Furthermore, studies 
of white matter variations have further validated the link between cortical excitability and 
connectivity (Klöppel et al., 2008; Siebner et al., 2009). Physiologically, it is important to 
note the effects of synaptic plasticity as these are the phenomena that are indirectly 
inferred through the connectivity analysis. Characteristically, long range interneurons are 
responsible for temporal synchrony of distant oscillators (Buzsaki, 2006).   
 
III. Computational Analysis 
 Computational models are another important tool to understand the effects of 
neuromodulation. Models created for MDD should account for the geometry and 
properties of the anatomical surface as well as the physics of the stimulation applied. The 
feasibility of patient-specific models has been displayed in characterizing the effects of 
DBS in Parkinson’s disease (Butson et al., 2007). These models provide an avenue for 
quantitative estimates of the effect of stimulation. Finite element methods (FEM) are 
employed to computationally model TMS. Studies show that complex cortical geometry 
has an effect on the electric field and the current densities that are produced on the 
cortical surface as a result of stimulation (Thielscher et al., 2011). Moreover, it is 
imperative to consider the complex biophysical properties of neuron-interneuron 
architectures as they vary and can be differentially recruited based on firing frequencies 
of the principal cells (Buzsaki, 2006).  
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 For cortical stimulation, one group (Holdefer et al., 2006) integrated white matter 
anisotropies with compartmental geometries and resistivities to predict the strength and 
location of current densities as a function of electrode location on the scalp. The Holdefer 
et al. model determined that at low stimulation intensities, small areas in white matter 
may be activated first depending on the dominant fiber orientation in that region. Another 
study (Wongsarnpigoon & Grill, 2008) investigated the role of electrode polarity in the 
modeling approach. They showed that the current density and activating function were 
greatest beneath the stimulating electrode. However, anodes targeted neurons that were 
oriented perpendicular to the cortical surface, whereas cathodes targeted those that were 
oriented in a parallel configuration. Wongsarnpigoon and Grill also demonstrated that the 
magnitude of the activating function was inversely proportional to the thickness of the 
cerebrospinal fluid (CSF) and dura. The practical application of these models is that 
several configurations of electrode placements and polarities can be used to selectively 
activate a region of the cortex. 
 Computational models also help interpret results from clinical studies and add to 
our knowledge of the underlying neurophysiology. Amatrudo et al. (2012) observed that 
structural differences between two neurons accounted for differences in passive 
properties but not action potential (AP) firing or synaptic response properties. The 
authors suggest that differences in functional properties at the single neuron level 
contribute to differences in network behavior. In addition, greater connectivity and 
dendritic complexity of DLPFC neurons support a high level of cognitive function. These 
insights can be used to plan and assess stimulation effects of neuromodulation at the 
MDD circuit.   
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CHAPTER 3: WHAT IS THE ROLE OF STIMULATION PARAMETERS IN 
PATIENT RESPONSE TO EPCS FOR MDD? 
 
 
 
I. Introduction 
The DLPFC is a potential target for EpCS therapy. Neuropsychological and 
neuroimaging studies have found the DLPFC to be functionally involved in mood 
disorders (Koenigs & Grafman, 2009; Ressler & Mayberg, 2007). More specifically, the 
L-DLPFC (Brodmann areas 9/46) is hypoactive in individuals suffering from MDD 
(Koenigs & Grafman, 2009; Sackeim, 2001). EpCS of the L-DLPFC was recently 
evaluated in an 11-patient safety and feasibility study (Kopell et al., 2011). This method 
is considered safer than techniques such as deep brain stimulation (Holtzheimer et al., 
2012; Lozano et al., 2008) (DBS) because it does not require penetration of the dura. It is 
also considered more focal than TMS or vagal nerve stimulation (VNS) because the 
electrodes are located directly adjacent to the neuroanatomical target region (Nahas et al., 
2010). 
A wide range of stimulation configurations are available for EpCS. These can 
strongly affect the strength and orientation of the induced electric field as well as the 
specificity of the neurons that are recruited (Nahas et al., 2010). The stimulation 
parameters (frequency, amplitude, pulse width) and the electrode contact locations are 
expected to be cofactors for the overall effectiveness of the treatment (Fregni et al., 2006; 
Lefaucheur, 2008). The orientation of the dendrites and axons in the induced electrical 
field further influences the direction of the polarizing effect (Lefaucheur et al., 2008; 
Manola et al., 2007). These orientations are highly correlated with a specific location on 
the cortical surface. An rTMS study (Herbsman et al., 2009) for depression over the 
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prefrontal cortex was conducted to validate the differential effects of location within the 
DLPFC. Herbsman et al. found a linear relationship between coil placement and the 
Hamilton Depression Rating scale (Hamilton, 1960) (HDRS-28) improvement. These 
findings illustrate the complexity associated with EpCS and the treatment of depression 
in terms of electrode location and stimulation protocol. 
A recent study reported on the feasibility of EpCS of L-DLPFC for the treatment 
of MDD (Kopell et al., 2011). Data from that previous trial were analyzed further as part 
of our current study to understand the degree to which stimulation parameters and 
electrode location were predictors of clinical response. The objective of this study was to 
estimate the degree of variability in HDRS-28 that is attributable to changes in 
stimulation protocol. In particular, the goals of this study were: 1) Determine whether 
changes in the stimulation protocol, which consisted mainly of varying anode/cathode 
configurations, had a differential effect on HDRS-28 2) Estimate the time necessary for 
treatment to elicit a robust clinical response; and 3) Explore the effects of stimulation 
location on clinical outcome. 
 
II. Methods 
Participants 
Data from eleven subjects (6 males, 5 females) with recurrent MDD without 
psychotic features were analyzed. The inclusion criteria for these patients have been 
described in a previous report (Kopell et al., 2011). Approval from the Institutional 
Review Board at the Medical College of Wisconsin was obtained prior to conducting the 
analysis. 
22 
 
 
Study Design 
Participants were randomly assigned to either 8 weeks of an initial sham period (n 
= 5) or active stimulation (n = 6). Patients in the sham group received active stimulation 
after the initial 8-week period. The stimulation study duration was 104 weeks with 
periodic assessments using HDRS-28 (primary outcome), and the following secondary 
outcomes: Montgomery-Asberg Depression Rating Scale (MADRS), Global Assessment 
of Functioning (GAF), and Quality of Life Enjoyment and Satisfaction Questionnaire 
(QLES). For the present analysis, only the HDRS-28 scores were used. 
Stimulation was applied using a two-electrode implantable paddle with platinum-
iridium contacts in the L-DLPFC. Electrode contacts were 3.75 mm in diameter and 15 
mm apart. They were implanted over the posterior half of the middle frontal gyrus. The 
implantable pulse generator (IPG), which was implanted in the sub-clavicular region, 
delivered continuous stimulation as specified by the stimulation protocol. Patients 
received repeated clinical evaluation during the study period. Clinical response was 
defined as 40% improvement from baseline HDRS-28 scores. Remission was defined as 
an HDRS-28 score of less than 10. 
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Figure 3.1: Site of 2-electrode paddle implant in the L-DLPFC. This figure was reprinted with permission 
from Kopell et al. Neurosurgery (2011) 
 
 
 
Stimulation Settings 
The IPG used in this study was capable of providing a range of stimulation modes 
that differed in polarity (anode or cathode), duty cycle (percentage of pulses that were 
active), and number of active contacts (one or two). Eight different stimulation modes 
were applied during the study. Each patient began with monopolar, anodal stimulation at 
50 Hz, 150µs pulse width (PW), and 6.5mA of total current. The first stimulation mode 
applied was Q03. In this mode both the anterior and posterior electrodes were anodic and 
the current was divided between them (3.25mA at each electrode). All patients were 
stimulated using this mode for the first 8 weeks of active stimulation. If this mode was 
effective, then other modes at reduced power were tried. First, modes Q29 (50% duty 
cycle of Q03) or Q28 (25% duty cycle of Q03) were tried to preserve effectiveness while 
simultaneously prolonging IPG battery life. If these modes failed to show an 
improvement, then the patient was switched to mode Q21, which provided unipolar 
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stimulation where the polarity toggled between anode and cathode in a pseudorandom 
manner. During this mode, output polarity was set to one of the four unipolar 
configurations every second where either electrode could be anodic, cathodic, or off. 
Because only one of the leads was active, all current (6.5mA) was delivered through the 
active electrode contact. Similar to Q03, if this mode was effective then the patient was 
switched to a lower power setting with mode Q37 (50% duty cycle of Q21) or Q36 (25% 
duty cycle of Q21) in an effort to extend IPG battery life. If none of these modes were 
effective, the clinician selected another appropriate setting. During the study, modes Q09 
(75% duty cycle) and Q12 (50% duty cycle) were administered occasionally. Both modes 
were characterized as anodic stimulation modes at decreased power. All modes were 
categorized in three groups: anodic at full power (Q03), anodic at reduced power (Q28, 
Q29, Q09, Q12), and mixed polarity (Q21, Q36, Q37). 
Data Analysis 
A cumulative incidence curve was calculated using the Kaplan-Meier survival 
algorithm to characterize the time necessary to observe a clinical effect of the treatment. 
The effect of stimulation mode on HDRS-28 over time was modeled via a piecewise 
linear mixed model. The baseline score and the slope of the change in HDRS-28 during 
each intervention mode (anodic full power, anodic reduced power, and mixed polarity) 
were included both as fixed and random effects. Thus, we could estimate the average 
over subjects while allowing for between-subject variability and incorporation of 
repeated measurements per subject. The change-points of the model were not estimated; 
the subject-specific times of mode change were used instead. The model was fitted using 
Proc Mixed in SAS 9.2 (SAS Institute, Cary NC). 
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Two graphs were generated from the fitted model. The first graph shows observed 
and predicted HDRS-28 trajectories for each patient over time with model-based 95% 
confidence intervals. According to the model, a particular mode within a patient had the 
same slope for each episode. The second graph shows the observed and fitted values of 
HDRS-28 change within each contiguous episode using the same mode; the value at the 
last observation of a previous mode has been subtracted from each observation at the 
subsequent mode. 
Stimulation Location 
 
 
Figure 3.2: A flowchart describing the process used to determine the stimulation location. Imaging data for 
4 subjects who were enrolled at the Medical College of Wisconsin were used to assess the effect of location 
on clinical outcomes. The presurgery MRI and postsurgery CT scans were co-registered to determine the 
site of implanted electrodes. The pial surface for each subject was then extracted via FreeSurfer (Martinos 
Center for Biomedical Imaging). The stimulated region of interest (ROI) was defined as a locus of points 
on the pial surface within a 1-cm radius of each electrode. Each patient ROI was then mapped to one 
patient brain for comparison. 
 
 
 
The study protocol required the electrodes to be placed on the L-DLPFC (Figure 
3.1). Imaging data for 4 subjects who were enrolled at the Medical College of Wisconsin 
were used to assess the effect of location on clinical outcomes. The preoperative 
magnetic resonance imaging (MRI) and postoperative computed tomography (CT) scans 
were fused using Analyze version 10 (AnalyzeDirect, Lenexa, KS) to determine the site 
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of the implanted electrodes. The pial surface for each subject was then extracted from the 
preoperative MRI via FreeSurfer (Martinos Center for Biomedical Imaging). A 
stimulated ROI, calculated and displayed using MATLAB (Mathworks Inc, Natick, MA) 
and SCIRun (Center for Integrative Biomedical Computing, University of Utah), was 
defined as a locus of points on the pial surface within a 1-cm radius of each electrode. 
The analysis for mapping the ROI did not take into account the difference between 
anodic and mixed stimulation. However, a quantitative comparison of the effects of 
stimulation polarity and location in between-subjects and within-subjects data is essential 
and should be addressed in future studies. Each patient ROI was then mapped to one 
patient brain, which served as an atlas brain, for comparison (Figure 3.2). The ROI for 
each patient was saved as a matrix of node values. These nodes were then mapped to the 
atlas brain using a template-matching algorithm in FreeSurfer. Lastly, the nodes were 
color coded in SCIRun based on maximum percent improvement observed in HDRS-28. 
   
III. Results 
Stimulation Effectiveness Varied as a Function of Mode and Duration 
Eleven patients were assessed over the course of 104 weeks. For the present 
analysis, all patients (active and sham) were normalized so that baseline (Week 0) was 
the point at which stimulation was turned on. Stimulation effectiveness as a function of 
duration and mode are shown in a piecewise linear mixed model for each subject (Figure 
3.3). Clinical response was defined as a 40% reduction in the HDRS-28 score from 
baseline. Eight subjects (Patients 1-8) were responders under this criterion. The linear 
models for each mode were grouped to their respective categories (anodic full power, 
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anodic reduced power, and mixed polarity) (Figure 3.4). A statistically significant 
improvement in HDRS-28 was observed during the application of anodic full power 
modes (slope = -0.109, p = 0.034). A statistically significant effect was also observed 
during the application of mixed polarity modes (slope = -0.26, p < 0.001). However, 
improvement during anodic reduced power modes did not reach significance (p > 0.05). 
Lastly, improvement during the initial 8-week period contributed greatly to the effect of 
anodic modes at full power (Figure 3.5). 
Response Probability Increased Over Time 
A Kaplan-Meier curve was used to determine the time necessary to observe a 
clinical effect of the EpCS (Figure 3.6). Analysis of the baseline HDRS-28 showed that it 
had no predictive effect on the time of response (p = 0.63).  Over 50% of the responses (5 
of 8) occurred within the first 20 weeks of the study as shown in Figure 3.3. In 
comparison, only three subjects displayed a clinical response at eight weeks, which was 
the end-point in the clinical trial. These results were generated using a 40% improvement 
threshold. When the response probability was evaluated with a threshold of 50% 
improvement from baseline, the results were similar. By week 20, 50% of the responses 
(3 of 6) had occurred. 
Stimulation Effectiveness Was Location-Dependent 
An average value for the maximum improvement from baseline HDRS-28 was 
calculated at each of the nodes that were mapped in the ROI. The improvement ranged 
from 52%-93%. Nodes in the medial and posterior areas correlated with lower 
improvement values (red) whereas those in the lateral and anterior areas correlated with 
higher improvement values (blue). This result suggests a trend that stimulation in the 
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lateral and anterior region of the L-DLPFC correlates with better clinical outcomes 
(Figure 3.7). It also illustrates a subregion within the L-DLPFC that could serve as a 
target for future therapies. 
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Figure 3.4: Piecewise linear mixed model for each mode. The slopes obtained for each contiguous 
stimulation mode as displayed in Figure 3.2 were grouped to study the effect of stimulation parameters. 
The improvement in HDRS-28 during the application of the anodic mode at full power was statistically 
significant (slope = -0.109, p = 0.034). Improvement in HDRS-28 during the mixed mode was also 
statistically significant (slope = -0.26, p < 0.001). However, anodic modes at reduced power did not have 
an effect on HDRS-28 (p>0.05). **Modes showed statistically significant improvement 
 
 
 
 
Figure 3.5: Responders versus nonresponders at 8 weeks. The effect of anodic mode at full power at initial 
versus later time points in both responders and nonresponders. The data shown are for responders (top 
panel, n = 3) and nonresponders (bottom panel, n = 8) during the initial 8 weeks of stimulation. The vertical 
lines in each plot indicate the initial 8-week period. Responders improved dramatically in the initial period 
and may have experienced a floor-effect, which limited further improvement. 
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Figure 3.6: Kaplan-Meier estimate of response probability. Each step in the solid black line indicates that 
one or more patients reached the response criterion. 
 
 
 
Figure 3.7: Stimulation in the lateral and anterior region of the L-DLPFC correlates with better clinical 
outcome. An average value for the maximum improvement from baseline HDRS-28 was calculated at each 
of the nodes that were mapped in the ROI. Improvement ranged from 52%-93%. Nodes in the medial and 
posterior areas were correlated with lower improvement values (red) whereas those in the lateral and 
anterior areas were correlated with higher improvement values (blue).  
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IV. Discussion 
The goal of this study was to assess the degree of variability in HDRS-28 due to 
changes in stimulation protocol or electrode location. In particular, the aims of this study 
were to determine if changes in the stimulation protocol (anode/cathode) had a 
differential effect on HDRS-28, to estimate the time necessary for treatment to evoke a 
clinical response, and to explore the effects of stimulation location on clinical outcome. 
Based on the effects of cathodal and anodal stimulation (Fregni et al., 2006; 
Lefaucheur et al., 2008), we expected the mixed polarity modes to have a minimal effect. 
Contrary to this theory, the results indicated a significant effect of the mixed mode on the 
improvement of HDRS-28. One reason for this effect could be the magnitude of the 
current delivered. Current delivery was more focused in the mixed mode because only 
one contact was active at a time during stimulation and therefore all of the current 
(6.5mA) was delivered through that electrode. Also, anodes and cathodes are selective in 
which neural elements are excited. Because the mixed polarity modes allowed for each 
electrode to serve as an anode and a cathode, a wider range of neural elements may have 
been recruited. Lastly, the direction of the activation is influenced by the orientation of 
dendrites and axons in the induced electrical field (Lefaucheur et al., 2008). The 
improvement due to mixed mode application could be attributed to the neuron 
orientation(s) underneath the cortical surface. This claim could be further investigated by 
exploring the effects of selective stimulation on the longitudinal outcomes of other 
neuromodulation techniques such as rTMS (see Chapter 4) that allow for control of the 
electric field orientation relative to cortical tissue. 
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The results demonstrate that improvement was also significant with the anodic 
full power modes. The effect of the anodic full power modes was observed mostly in the 
initial period (8 weeks), and in some patients most of the improvement was achieved 
during this period. Therefore, due to a floor-effect, other modes may have been unable to 
further improve the response (Figure 3.5). When looking closely at the data, the subjects 
can be divided into fast versus slow responders. The floor-effect could be observed in the 
fast responders. Ideally, a statistical comparison of anodic full power modes applied 
initially versus later in the study would provide more perspective. However, due to 
limited data points for the latter condition, this analysis was not possible. A similar trend 
was observed for HDRS improvement in a DBS study for MDD during the initial 2 
months of treatment (Lozano et al., 2008). It is also essential to note the effects of duty-
cycle on clinical outcome since discontinuous stimulation may have an impact on the 
long-term sustainability of treatment (Nahas, 2010). However, according to our results, 
the intermittent stimulation, which was characterized by a lower duty cycle (anodic 
reduced power), was not effective. 
The time course for response to EpCS was variable, which could result from 
many factors including characteristics of the patient, life events that occurred during the 
study period, stimulation location, and stimulation protocol (including mode). There are 
periods of improvement in individual patients during which the stimulation protocol was 
fixed and the HDRS-28 scores declined steadily over several weeks. Hence, the data 
suggests that therapeutic response is due to some type of plasticity brought about by 
chronic stimulation. Cortical excitability is modulated by altering resting potential during 
stimulation and by modifying synaptic transmission (Boggio et al., 2008; Liebetanz et al., 
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2002). Also, the neurochemical and neuroendocrine processes that are responsible for 
expression of secondary messengers are time consuming and complicate the 
programming algorithms necessary to observe efficacy in EpCS (Lefaucheur et al., 2008). 
When considering the results of different stimulation modes, it is important to note the 
possibility of metaplasticity. Metaplasticity is a term used to describe the changes that 
occur in plasticity due to neuronal influences from previous treatments steps and 
medications. This phenomenon can influence subsequent changes in plasticity and affect 
both response and relapse. 
 MDD is widely accepted to be heterogeneous (Krishnan & Nestler, 2008) and, 
therefore, patient response rates inherently vary. A recent pharmacological study, 
Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial (Rush et al., 
2006), concluded that remission rates decrease with an increase in the number of acute 
treatment steps. Despite the longer amount of time taken by some of the subjects to reach 
remission, the study noted that remission was associated with better prognosis even when 
achieved after numerous treatment steps. Thirty-five percent of patients with MDD 
required more than eight weeks to reach remission with their first antidepressant. This 
conclusion further emphasizes that physiological change necessary to cause and sustain 
improvement occurs at different rates in different individuals. The results of our response 
probability analysis suggest that in order to observe a clinical response in over half the 
responders, the treatment outcome should be evaluated at 20 weeks instead of 8 weeks. In 
another recent EpCS study (Nahas et al., 2010), average improvement in HDRS-24 was 
about 36% from baseline at 16 weeks whereas at 28 weeks the average improvement 
increased to 55% from baseline. These findings further support our results. 
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L-DLPFC plays a major role in neuropsychological disorders and tends to be 
hypometabolic in MDD. To evaluate the effects of location on stimulation, a transcranial 
direct current stimulation (tDCS) study (Boggio et al., 2008) compared stimulation at the 
prefrontal cortex with an active control group that was stimulated at the occipital cortex. 
At the end of the Boggio et al. study, there were a significantly greater number of 
responders in the active treatment group than in either the sham or the active control 
group. However, L-DLPFC defines a fairly broad area and stimulating at this target is 
still imprecise. It is unclear where electrodes should be placed during EpCS in order to 
maximize efficacy of the treatment. The last analysis in this study was aimed at exploring 
the effects of stimulation location on clinical outcome. Our data suggests a trend in which 
stimulating in the anterior and lateral regions of the L-DLPFC is more efficacious than in 
the posterior and medial regions (Figure 3.7). This finding is significant as it emphasizes 
the importance of stimulation location. With an anterior and lateral placement of the 
electrode, the stimulation is more likely to be in an effective region of the DLPFC. In a 
rTMS study for depression (Herbsman et al., 2009), 54 patients were stimulated over the 
prefrontal cortex for 3 weeks. Herbsman et al. found a linear relationship between coil 
placement and HDRS improvement. According to their results, there was a 5 mm 
difference in the average coordinate position of the non-responders and the responders in 
all three axes (x, y, z). They were unable to observe the same dependence on the coil 
position in the placebo group. Likewise, they also concluded that stimulating lateral and 
anterior in the DLPFC was associated with better clinical response. 
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V. Conclusions 
In general, clinical trials are designed to tightly control treatment such that 
outcome variability is attributed to differences among patients in the study cohort. 
However, neuromodulation therapies such as EpCS have many additional sources of 
variability including electrode location and stimulation protocol. The methods used in 
this study confirm that quantitative comparison of stimulation among different patients 
can be accomplished by a pipeline of analysis tools. The results of our study contribute 
largely to the understanding of EpCS. We also believe that this approach can inform 
many types of neuromodulation studies by first quantifying where and how individual 
patients were stimulated, and second by correlating stimulation location with 
effectiveness. Importantly, we believe that this approach can provide insights whether or 
not a study reached its therapeutic objectives. 
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CHAPTER 4: WHAT FUNCTIONAL CHANGES RESULT FROM rTMS FOR 
MDD? 
 
 
 
I. Introduction 
Due to the heterogeneity of MDD, about a third of the patients suffering from the 
disorder are resistant to pharmacological antidepressants and/or psychotherapy. 
Neuromodulation therapies have emerged as potential treatments for depression. As 
described previously, DLPFC and VMPFC are two of the main targets of 
neuromodulation therapy. DBS at the sACC of the VMPFC network has shown 
promising results with inhibitory stimulation (Hamani, Diwan, Isabella, et al., 2010; 
Hamani et al., 2011; Holtzheimer et al., 2012; Lozano et al., 2008; Mayberg, 2009; 
Mayberg et al., 2005). Similarly, excitatory, noninvasive stimulation at the DLPFC via 
rTMS has efficaciously ameliorated depression for patients in several studies (Downar & 
Daskalakis, 2013; Fitzgerald et al., 2009; Herbsman et al., 2009; O’Reardon et al., 2007). 
Lesion studies and advances in neuroimaging have provided evidence of the role of PFC 
in depression. First of all, these two targets exhibit opposite metabolic activity in the 
pathological depressed state (VMPFC: hyper, DLPFC: hypo) (Koenigs & Grafman, 2009; 
Pathak et al., 2012; Ressler & Mayberg, 2007). We applied rTMS at the DLPFC because 
it is superficial enough to access noninvasively and still plays a major role in higher 
cognitive functions and affective regulation. 
We used resting-state MEG to assess the longitudinal changes that resulted due to 
high-frequency rTMS therapy. MEG is a functional neuroimaging method that senses 
magnetic fields generated by neural activity. Specifically, these recordings represent the 
sum of thousands of synchronous postsynaptic currents in pyramidal neurons (Figure 
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2.1). Choosing MEG over fMRI or EEG for this study is fitting due to its excellent 
millisecond-level temporal resolution and the reliability of fields that are less distorted 
due to the skull and the scalp allowing for a more robust analysis at the source level to 
characterize regional activity as well as connectivity based on time-dependent measures 
(Baillet et al., 2001; Gross et al., 2013). Recent studies have investigated TMS as both a 
priming method and a treatment option for depression (Herbsman et al., 2009; Nahas et 
al., 2001; O’Reardon et al., 2007). Location of stimulation and intensity, which is 
determined based on RMT, are important parameters in rTMS therapy. 
Efficacy of rTMS therapy in treating MDD has previously been established and is 
not the focus of this study. Rather, the current study aims to identify objective indicators 
of antidepressive response to rTMS using functional neuroimaging. The long-term goal is 
to determine which patients will respond to anti-depressive treatment and to customize 
neuromodulation therapy accordingly. We are interested in two primary questions: 1) 
Which depressive circuits previously targeted for DBS are modulated during successful 
rTMS therapy for MDD? 2) Can changes in functional connectivity predict clinical 
response? Our hypothesis is that modulation of the L-DLPFC will be reflected through 
longitudinal changes in the power spectrum of MEG results and changes in functional 
connectivity with other targets of the depressive circuit.  
 
II. Methods 
rTMS delivery 
High frequency (10 Hz) rTMS was administered to the L-DLPFC (Brodmann 
areas 9 and 46) in five MDD patients (n=5) according to an IRB approved protocol. A 
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total of 1000 biphasic pulses were delivered in 25-second cycles (5 seconds on, 20 
seconds off) over 20 trains per session using a Magstim Rapid stimulator (Magstim 
Company Limited, Whitland, UK). Treatment was delivered for five 15-minute sessions 
per week over four weeks. Stimulation was applied at 110% of RMT, which was 
determined by stimulating the hand-knob of motor cortex. Periodic behavioral 
assessments were performed with the Montgomery-Asberg Depression Rating Scale 
(MADRS). 
Anatomical Imaging 
High-resolution (3T) structural MRI was acquired before treatment to assist with 
targeting and navigation. It was used for 3D reconstruction of the head volume (scalp, 
skull, cortex) using FreeSurfer (Dale et al., 1999) (Martinos Center for Biomedical 
Imaging) and Brainstorm (Tadel et al., 2011). The ANT neuro-navigation system was 
used for accurate real-time targeting, and to record the position and orientation of the 
TMS coil during each pulse (+x towards the nose, +y towards the left ear, and +z in the 
superior direction with the origin at the center of the head) (Figure 4.1). 
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Figure 4.1: Neuronavigation for rTMS therapy. Subject-specific MRI was used for 3D reconstruction of the 
head volume. High-frequency rTMS (10Hz) at 110% of the RMT was then applied at the L-DLPFC with 
real-time targeting using the ANT neuro-navigation system. 
 
 
 
Functional Imaging 
MEG was recorded at 1024 Hz using a 306-channel VectorView system (Elekta 
Neuromag Ltd, Helsinki, Finland). EOG and EKG were also recorded simultaneous to 
MEG for post-hoc artifact removal. MEG was acquired at four time points: before 
treatment, halfway through the treatment course (2 weeks), at the end of the treatment 
course (4 weeks), and two months after the end of treatment. Empty-room recordings 
were also collected at these acquisitions to use for noise modeling. During MEG, the 
subject was in the supine position with sensors positioned above the head. A total of 24 
minutes of data was collected in four 6-minute runs. Each condition (eyes-open and eyes-
closed) was repeated once. 
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Source Analysis 
MEG data for the eyes-closed condition were analyzed for cortical source 
modeling, power spectral density (PSD), and functional connectivity using Brainstorm 
(Tadel et al., 2011). The results were assessed to identify longitudinal changes in PSD 
over standard frequency bands of ongoing oscillatory neural activity. Continuous signals 
were cleaned with the signal-space separation (SSS) method (Taulu et al., 2005) and 
further corrected with the signal-space projection (SSP), a method based on principal 
components analysis to eliminate artifacts caused by eye-blinks and heartbeats, all using 
default settings in Brainstorm. The data was further processed with a 60-Hz notch filter 
and a 2-Hz high-pass filter to remove residual noise due to the power line and effects of 
the DC offset. 
The weighted minimum-norm estimate (wMNE), a subtype of distributed source 
models, was used to generate the source image maps (Eq 3-6), with default imaging 
parameters in Brainstorm. Elementary dipole current sources were constrained 
perpendicularly to the individual cortex; additive sensor noise was modeled with a 
Gaussian distribution with known covariance statistics estimated from empty-room 
recordings. The Welch periodogram (Eq 7-8) was used to obtain the PSD of each 
individual source time series on the cortex. Signals from the L-DLPFC were averaged to 
determine the power at that region. For this analysis, L-DLPFC was defined based on the 
Desikan-Killiany atlas (Desikan et al., 2006) from FreeSurfer. A linear regression 
analysis was performed in MATLAB (Mathworks Inc, Natick, MA) to determine if 
power within a particular frequency band was correlated with clinical improvement. Data 
was grouped in time (baseline, midpoint, endpoint, follow-up) and a t-test was conducted 
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between the four slopes to determine if there was a significant linear correlation between 
power in L-DLPFC and MADRS. 
Functional Connectivity 
Coherence measures (Eq 9) were used to determine functional connectivity 
between L-DLPFC and several regions previously investigated for DBS therapy:  
pregenual anterior cingulate cortex (pACC) and sACC, NAc, and amygdala.  The 
Desikan-Killiany atlas (Desikan et al., 2006) from FreeSurfer was used to define the 
ROIs. For our connectivity analysis, a sub-region of the L-DLPFC was defined as a 30-
cm
2
 area. This value for the patch of cortex was approximated based on previously 
developed computational models that showed the extent of where the most excitable 
neurons were (Goodwin Dissertation 2014). Once again, data was grouped in time and a 
regression analysis similar to that of PSD was conducted to determine if there was a 
significant linear correlation between coherence (L-DLPFC/ROI) and MADRS  In 
addition, a cluster analysis was conducted in MATLAB and visualized in SCIRun 
(Center for Integrative Biomedical Computing, University of Utah). For this analysis, 
each node on the L-DLPFC surface was assigned a mean connectivity score based on its 
coherence with the signals at all nodes in the ROI.  A colormap was then used to 
visualize the differential effects of sub-regions in the L-DLPFC.   
 
III. Results 
Data from four responders and one non-responder were analyzed in this study. 
Clinical response was defined as 40% reduction in MADRS scores from baseline. 
Stimulation was applied to the L-DLPFC using a predefined target coordinate on an 
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anatomical MRI. Within the FreeSurfer-defined L-DLPFC, placement of the stimulation 
target did not differ between subjects. By midpoint, an improvement in depressive 
symptoms was observed in responders (Table 4.1). These responders continued to 
improve during treatment and were still in remission at follow-up (Figure 4.2). 
 
 
MADRs scores over the course of rTMS for depression 
 Dep01 (R) Dep02 (NR) Dep04 (R) Dep05 (R) Dep06 (R) 
Baseline 26 20 24 26 34 
Midpoint 6 22 17 17 16 
Endpoint 4 28 10 10 5 
Follow-up 10 28 8 7 2 
Table 4.1: Summary of MADRS scores for all subjects over 4 weeks of rTMS therapy and at 12-week 
follow-up (R=Responder; NR=Non-responder) 
 
 
 
Figure 4.2: Relationship between MADRS scores and time. It is apparent from this plot that drastic 
improvement occurred in responders during the course of treatment which persisted at least for another 
eight weeks as demonstrated by the scores at follow-up. 
 
 
 
Increase in high-frequency power at the L-DLPFC correlates with an improvement 
in depressive symptoms 
The results from the PSD analysis indicated that an increase in ongoing gamma 
(γ) (30-59 Hz) power at the L-DLPFC significantly correlated (p(γ) = 0.02) with an 
44 
 
 
improvement in depressive symptoms. A power distribution over cortical maps (Figure 
4.3) showed a marked increase bilaterally in the frontal regions for responders throughout 
the course of treatment. These observations were corroborated by a linear regression 
analysis (Figure 4.4). 
 
  
45 
 
 
A: Changes in Delta Power over the Cortical Surface 
 
 
B: Changes in Theta Power over the Cortical Surface 
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C: Changes in Alpha Power over the Cortical Surface 
 
 
D: Changes in Beta Power over the Cortical Surface 
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E: Changes in Gamma Power over the Cortical Surface 
Figure 4.2: Changes in power spectral density (PSD) in source space. These cortical maps display the 
normalized difference in PSD from baseline in standard frequency bands (delta (A), theta (B), alpha (C), 
beta (D), and gamma (E)). For the responders, there is a marked increase in high-frequency power (E: 
gamma) bilaterally in the frontal regions, which corresponds to their improvement in depressive symptoms 
as determined by the change in MADRS (right column for each patient). A similar trend, specific to the 
responders, is not observed in the lower frequency bands. 
 
 
 
 
Figure 4.4: Increase gamma power at the L-DLPFC is correlated with an improvement in depressive 
symptoms. Linear regression models of MADRS versus PSD grouped in time for gamma band, including 
all subjects, show that an increase in high-frequency power is indicative of lower MADRS or better clinical 
outcome. Each symbol represents a different subject. 
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Opposite effects of functional connectivity in high and low frequency bands between 
L-DLPFC and remote regions  
Changes in functional connectivity of L-DLPFC and several regions of interest 
(ROI) in the depressive circuit were observed. An increase in mean coherence in the delta 
band correlated with better clinical outcome for depression in the connectivity analysis 
between L-DLPFC and pACC (p = 0.03) and between L-DLPFC and amygdala (p = 
0.03) as shown with a linear regression of MADRS versus coherence (Figure 4.5). In 
contrast, a decrease in mean coherence in the gamma band correlated with better clinical 
outcome in the connectivity analysis between L-DLPFC and sACC (p = 0.01). Also, this 
increase in coherence from baseline to endpoint in delta band was observed over the 
entire area of stimulation for the responders when mapped onto the cortex. Furthermore, 
the nodes involved in modulating connectivity were common for amygdala and sACC 
(Figure 4.6). 
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(A) 
 
(B) 
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(C) 
 
Figure 4.5: Increase in delta connectivity between L-DLPFC/pACC (A); L-DLPFC/amygdala (B); and 
decrease in gamma connectivity between L-DLPFC/sACC. Linear regression models of MADRS versus 
coherence show that there is a significant linear relationship between connectivity and an improvement in 
depressive symptoms.  
 
 
 
Opposite modulation of functional connectivity in the cortico-limbic circuit 
over the course of rTMS therapy in high and low frequency bands 
 
Figure 4.6: rTMS modulates connectivity over the L-DLPFC in responders. L-DLPFC/amygdala coherence 
in delta band (bottom) increased from baseline to endpoint over the entire area of stimulation for 
responders. An opposite effect was observed with a decrease in L-DLPFC/sACC coherence in gamma band 
(top) from baseline to endpoint over the entire area of stimulation for responders. The nodes in L-DLPFC 
contributing to change in connectivity are common for both amygdala and sACC for all patients. 
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IV. Discussion 
The target of rTMS stimulation is the L-DLPFC as this region tends to show 
diminished function in individuals with MDD. This area is implicated in working-
memory tasks, attention, and long-term memory storage and consolidation. Our results 
support the hypothesis that longitudinal changes are reflected in the PSD and connectivity 
analyses of ongoing MEG data in the resting-state.  
An increase in gamma power at the L-DLPFC was correlated with an 
improvement in depressive symptoms. We posit that this increase may reflect a rise in 
metabolic activity of the DLPFC, which contributes to improvement of symptoms. 
Gamma oscillations have previously been linked to increased attentional processes 
(Benchenane et al., 2011). One mechanism of gamma modulation at a pharmacological 
level involves GABAergic interneurons. These cells contribute to synchronization of the 
pyramidal neurons in the DLPFC during tasks that require increased cognitive effort. 
Furthermore, GABA-mediated inhibition has shown to be sufficient in generating gamma 
oscillations (Barr et al., 2009).  
Previous evidence also points to GABAergic involvement in antidepressant 
response (Bajbouj et al., 2005; Yue et al., 2009). Animal models of depression have 
shown that GABA agonists have antidepressant activity (Petty, 1995; Yue et al., 2009). If 
inhibition is facilitated by fast acting GABAA receptors, oscillation frequency will 
correspond to the gamma band (Buzsaki, 2006). Therefore, an increase in gamma power 
for responders can be attributed to GABA-mediated inhibition. Another consequence of 
GABA-mediated inhibition is synchronization of large neuronal populations, leading to 
increased long-range functional connectivity (Fingelkurts et al., 2004). Changes in 
52 
 
 
synaptic plasticity are directly related to changes measured in functional connectivity and 
the strength of a synapse can further dictate the effect of inhibition (Buzsaki, 2006). The 
depressive circuit targeted for DBS includes amygdala, pACC, sACC, and the NAc 
(Holtzheimer & Mayberg, 2011; Krishnan & Nestler, 2008; Ressler & Mayberg, 2007). 
The most effective targets for DBS are sACC and amygdala. This evidence further lends 
credence to our results that imply the significance of modulating connectivity between 
these specific regions (L-DLPFC/sACC , L-DLPFC/pACC and L-DLPFC/amygdala).  
Activity in sACC contributes greatly to limbic-cortical dysregulation (Greicius et 
al., 2007; Mayberg, 1997). Depression severity has been shown to correlate positively 
with functional connectivity in sACC. In addition, increased connectivity of the default 
mode network in depression was also driven by this region (Greicius et al., 2007). Fox et 
al. also showed that the magnitude of relative disconnectivity (anticorrelation) between 
L-DLPFC and ACC was indicative of depression severity (Fox, Halko, et al., 2012). The 
distinct role of subregion functional connectivity is corroborated by differential 
anatomical connectivity of the pACC and sACC, suggesting a strong connection of 
pACC to frontal regions versus sACC to limbic regions (Johansen-Berg et al., 2008). 
These studies support our observed results of increased coherence with an improvement 
in depressive symptoms, suggesting that part of the antidepressant mechanism of rTMS 
may be remote suppression of the sACC, as this region has been shown to be 
hypermetabolic in depressed individuals.  
Another noteworthy finding is that the decrease in coherence was constrained to 
the gamma band for sACC, whereas the increase in coherence was observed in delta band 
for pACC and amygdala. Different frequency bands may enable the multiplexing of 
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channels of communication for different functional brain networks. Communication 
through coherence is usually controlled by inhibitory windows (Benchenane et al., 2011). 
Functional connectivity in lower frequency bands has been associated with higher 
cognitive tasks. Previous research has also demonstrated that anatomically distributed 
EEG coherence increased in lower frequencies, particularly the delta band during creative 
thought (Gruzelier, 2009; Petsche, 1996). Furthermore, neuroimaging and 
neurophysiological studies have reported that long-distance integration is coordinated by 
lower frequencies, whereas short-distance networks are coordinated by higher 
frequencies (Buzsaki, 2006; Leuchter et al., 2012). In particular for mood disorders, an 
fMRI study (Anand et al., 2005b) showed an increase in low-frequency BOLD (Blood-
oxygen-level dependent) fluctuation (LFBF) correlation between ACC and limbic regions 
in patients after treatment for depression. Another study (Chepenik et al., 2010) identified 
a negative correlation in low-frequency resting-state fMRI activity between the ventral 
PFC and amygdala in healthy subjects compared to those with bipolar disorder.  These 
reports corroborate our current findings of increased connectivity in the delta band 
correlating with better clinical outcome.  
According to an MEG study (Hillebrand et al., 2012) on resting-state functional 
connectivity, there is a positive correlation between patterns of source power and 
functional connectivity. A modeling study (Chawla 1999,2000) also showed increased 
phase locking between two connected neuronal populations resulting in increases in both 
power and functional connectivity. Based on these studies and the findings for increased 
gamma power in L-DLPFC that relate to increased metabolic activity in that region, we 
suggest that the decreased gamma connectivity with sACC is a result of decreased 
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gamma power at the sACC and hence lower source activity. As described earlier, 
decreasing metabolic activity in sACC has corresponded to an improvement in depressive 
symptoms for various antidepressant studies. 
Lastly, the modulation in coherence between frontal and limbic regions was 
observed over the entire area of stimulation for responders when mean connectivity was 
mapped onto the L-DLPFC. This finding implies that stimulation of responders engaged 
functional connections that were relevant for clinical improvement and nonresponders 
were effectively lacking in engaging those essential connections. In a previous study 
investigating EpCS for depression (see Chapter 3) (Pathak et al., 2012), stimulation using 
the mixed mode polarity, in which the configuration of the active electrode alternated 
between anode and cathode in a pseudorandom manner, was effective in achieving an 
antidepressant response. This response was likely due to recruitment of a wider range of 
neurons owing to characteristic differences in anodic and cathodic stimulations (Pathak et 
al., 2012; Wongsarnpigoon & Grill, 2008). Another study (Riva-Posse et al., 2014) 
investigating fiber tracts concluded that the involvement of bilateral forceps minor, 
cingulate bundle, and short descending midline fibers was predictive of clinical response. 
Riva-Posse et al. emphasized that the anatomical location of active electrodes was not the 
source of variability, but instead it was the hub location where these three fibers 
intersected that determined potential of response. 
 
V. Conclusion 
There are a few limitations that should be addressed in future studies as the field 
advances. First, interaction of TMS with prescribed medication is not clearly understood. 
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There is a possibility that changes in medication can affect cortical excitability which 
might necessitate a re-evaluation of the TMS “dose”. Additionally, we analyzed data 
from a small sample size. However, our findings are robust for all patients and the results 
are selective for specific targets. A comparison of PSD in the right occipital cortex as a 
control region did not result in a linear trend similar to the one observed at the L-DLPFC. 
The primary finding from this study is that in addition to local changes, high-frequency 
rTMS modulates several nodes of the depressive circuit during an effective clinical 
response. We postulate that this approach could provide valuable insights about patients 
evaluated for DBS surgery by advising physicians about which regions and functional 
connections to focus on for a robust response.   
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CHAPTER 5: HOW DOES STIMULATION OF DIFFERENT TARGETS IN THE 
DEPRESSIVE CIRCUIT AFFECT ANTIDEPRESSIVE RESPONSE? 
 
 
 
I. Introduction 
MDD is a highly disabling condition that affects a sixth of the American 
population (Kessler et al., 2005; Krishnan & Nestler, 2008). Because of its heterogeneity, 
many patients are resistant to commonly prescribed therapies. In recent years, 
neuromodulation therapies such as deep brain stimulation (DBS), chronic epidural 
stimulation (EpCS), and repetitive transcranial magnetic stimulation (rTMS) have found 
some success with treating this population. However, there are differing theories 
regarding the etiology of depression that have led to an investigation of several targets for 
neuromodulation therapy with variable efficacies. In particular for DBS, studies have 
focused on the sACC, ventral capsule/ventral striatum (VC/VS), medial forebrain bundle, 
and  NAc (Bewernick et al., 2010, 2012; Coenen et al., 2010; Holtzheimer et al., 2012; 
Malone et al., 2009; Mayberg et al., 2005; Schlaepfer et al., 2013). 
Effects of differences within a target have been evaluated previously for 
Parkinson’s disease (Nestor et al., 2014). In the Nestor et al. study, the hypothesis was 
that stimulation to specific subregions or neighboring fiber bundles would engage remote 
areas and result in better motor outcomes. Similarly, there is increasing evidence to 
approach MDD as a circuit-level disorder. A recent study demonstrated that clinical 
response was predicted by stimulation of specific white matter pathways and not just the 
anatomical location of active electrodes (Riva-Posse et al., 2014). The motivation for this 
study was to assess variability within a site of stimulation to better understand clinical 
improvement due to DBS for depression.  
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We studied a rodent model to answer the question, can variability in electrode 
placement account for behavioral differences in an antidepressive-like response? Animal 
models are valuable in providing insights about in vivo effects of DBS while allowing for 
a controlled environment (Cohen et al., 1998; Hamani, Diwan, Macedo, et al., 2010; Lim 
& Helpern, 2002). We investigated DBS at the ventromedial prefrontal cortex (VMPFC), 
white matter fibers of the frontal region (WMF), and NAc to evaluate the effects of 
stimulation location within these target regions.   
As these three structures are interconnected to some degree, an initial hypothesis 
was that by stimulating them, we would be modulating the same circuit at different 
levels. However, Hamani et al. have recently shown that, despite similar antidepressive-
like responses, DBS at these regions induces specific patterns of metabolic activity and 
functional connectivity, as measured by zif268 expression (Hamani et al., 2014).  
One of the most commonly used and validated preclinical screeners for the 
effectiveness of antidepressant medications or neuromodulation techniques is the forced 
swim test (FST) (Hamani & Temel, 2012). The degree of behavioral response varies 
between individuals regardless of the treatment. In this chapter, we investigated whether 
small variations in electrode placement within the VMPFC, WMF, and NAc can account 
for notable differences in behavioral outcomes in rats given DBS during the FST. We 
hypothesized that improvement in behavior is spatially dependent on stimulation location 
within a target. 
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II. Methods 
Male Sprague-Dawley rats (250-300 g) were anesthetized with halothane and 
electrodes were implanted in one of the following targets (Paxinos and Watson, 1998): 1) 
VMPFC; anteroposterior (AP) + 3.0 mm, lateral (L) ± 0.4 mm, and depth (D) 5.6 mm; 2) 
WMF (forceps minor) AP +2.7 mm, L 1.4 mm, D 5.6 mm; 3) NAc AP +1.6 mm, L 1.2 
mm, D 8.0 mm. Monopolar stainless steel electrodes (250 µm in diameter and 0.5 mm of 
exposed surface) were used as cathodes. An epidural screw placed over the 
somatosensory cortex was used as the anode (AP 0.5, L ± 1.5, D 1.0 mm) (Paxinos and 
Watson, 1998). Controls had holes drilled into the skull but were not implanted with 
electrodes. The VMPFC target has been considered homologous to the human sACC. The 
WMF target was chosen because it is the largest frontal brain structure containing both 
commissural and projection fibers. This target is not a homolog of the anterior limb of the 
internal capsule (ALIC), but it is partially composed of cortical projections that innervate 
the thalamus, basal ganglia, and brainstem nuclei.  
The FST was conducted one week after electrode implantation. On testing day one, 
rats were individually placed in a cylinder filled with 25 ± 1°C water for 15 minutes 
(Detke and Lucki, 1996; Detke et al., 1995). Thereafter, DBS-treated animals received 
continuous stimulation for four hours (ANS model 3510) at 100μA, 130Hz, and 90μsec 
(Hamani, Diwan, Isabella, et al., 2010). On the following day, rats in the DBS groups 
received two hours of stimulation followed by a five-minute swimming session during 
which the predominant behavior (immobility, swimming, or climbing) of the animals was 
scored at five-second intervals (Detke and Lucki, 1996; Detke et al., 1995). 
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Animals were sacrificed an hour after behavioral testing by decapitation following 
ketamine/xylazine anesthesia. We used in situ hybridization using 
35
S-UTP labeled 
riboprobes to measure zif268 (Hamani et al., 2014a; Creed et al., 2012). After 
hybridization, slides were exposed to Kodak BioMax film for 6 days at 4°C with 
calibrated radioactivity standards. Film analyses were conducted with an MCID system 
(Interfocus, UK).  
We conducted a probabilistic analysis (Figure 5.1) using MATLAB (Mathworks 
Inc, Natick, MA) to evaluate within-target effects of stimulation. The coordinates of 
electrode implants for all animals were determined from histology and mapped onto the 
Paxinos atlas. Electrode locations from the right hemisphere were mirrored onto the left 
hemisphere for this analysis as confirmed by histology. One immobility score was 
assigned per rat, which corresponded to both left and right electrodes in that particular 
animal. Next, a volume of tissue activation (VTA) was computed based on a multi-
compartment model of excitable neuronal elements around each electrode location using 
stimulation parameters. A binary mask was created to label voxels within the sum of 
VTAs for a particular target. Each voxel was then assigned an average immobility score 
based on the results of the FST from every rat. Only voxels contained within two or more 
VTAs were included in the average analysis. The mapped scores (average immobility per 
voxel) were visualized in SCIRun (Center for Integrative Biomedical Computing, 
University of Utah) to further explore the effects of DBS within a particular target.  
We further explored the data by examining the distribution for each target. If the 
distribution of the data or its residuals was normal, a generalized linear regression (Eq 
11) model was used to determine the significance and magnitude of the effect of location 
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in each axis (M-L, D-V, A-P). All statistical analysis was done in MATLAB (Mathworks 
Inc, Natick, MA). 
 
 
Figure 5.1: Probabilistic analysis of improvement with DBS for depression. Stimulation locations for all 
animals in both hemispheres were mapped on the Paxinos atlas. Subsequently, a volume of tissue activated 
(VTA) was computed to determine the extent of stimulation. Lastly, behavioral scores from the FST were 
mapped onto VTA voxels for spatial analysis. 
 
 
III. Results 
Antidepressive response was related to stimulation in the anterior region of VMPFC 
Data from 29 male Sprague-Dawley rats were analyzed in this study. Eleven rats 
(22 hemispheres) were bilaterally implanted in the VMPFC. Stimulation was constrained 
in the A-P axis from Bregma 2.20 mm to Bregma 3.70 mm. Average immobility scores 
per voxel ranged from 54.9 to 89.3 and were normally distributed (Figure 5.2A). A linear 
regression model indicated a significant effect of location in all axes with the highest 
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magnitude in the D-V and A-P axes (Table 5.1, Figure 5.3A). Higher immobility scores 
were correlated with stimulation in the dorsal/posterior region versus the anterior regions 
of the VMPFC (Figure 5.4). Also, voxels that represent the highest immobility were in 
the vicinity of the infralimbic cortex (IL)/ prelimbic cortex (PrL) border.  
 
Spatial dependence of stimulation at the VMPFC 
Variable Coefficient (β) Std. error p-value 
intercept 128.91 3.26 < 0.01 
x (M-L) 2.06 0.73 < 0.01 
y (D-V) 9.49 0.59 < 0.01 
z (A-P) -6.20 0.41 < 0.01 
Table 5.1: Regression table for general linear model of stimulation in the VMPFC 
 
 
 
Antidepressive response was related to stimulation in the lateral region of NAc 
Eight rats (16 hemispheres) were bilaterally implanted in the NAc. All stimulation 
was constrained to the accumbens core (Bregma 1.20 mm- Bregma 1.70 mm). Compared 
to other targets, NAc displayed a better antidepressive response. Overall, the range of 
average immobility per voxel for stimulation in the NAc was 47.3 to 79.5 with a 
segregated distribution, but normal distribution of residuals (Figure 2B). For the NAc, a 
linear regression fit indicated a significant effect in the M-L and A-P with high 
magnitude (Table 5.2, Figure 5.3B). Higher immobility was correlated with stimulation 
in the lateral/posterior region versus medial region of the activated surface (Figure 5.5). 
 
 
  
Spatial dependence of stimulation at the NAc 
Variable Coefficient (β) Std. error p-value 
intercept 34.86 36.11 0.33 
x (M-L) 24.29 1.98 < 0.01 
y (D-V) 0.60 5.36 0.91 
z (A-P) -10.45 2.54 < 0.01 
Table 5.2: Regression table for linear regression of stimulation in the NAc 
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Antidepressive response was related to stimulation in the dorsal region of WMF 
Ten rats (20 hemispheres) were bilaterally implanted at the WMF of the frontal 
regions ranging from Bregma 2.2 mm to Bregma 2.7 mm in the A-P axis. Average 
immobility per voxel ranged from 67.9 to 91.7 with a segregated distribution, but normal 
distribution of residuals (Figure 2C). The response due to stimulation was significant in 
the D-V axis around y = 4.8 mm (distance from the horizontal plane passing through 
Bregma and Lambda on the surface of the skull) with a high magnitude of effect (Table 
5.3, Figure 5.3C). The trend indicates higher immobility in the ventral region versus 
dorsal region of the activated surface of WMF (Figure 5.6). 
 
Spatial dependence of stimulation at the WMF 
Variable Coefficient (β) Std. error p-value 
intercept  -3.02 2.54 0.23 
x (M-L) 1.86 1.02 0.06 
y (D-V) -13.85 0.62 < 0.01 
z (A-P) 4.92 0.98 < 0.01 
Table 5.3: Regression table for linear regression model of stimulation in the WMF 
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Figure 5.2: Distribution of depression scores at each target (left) and respective residuals (right). VMPFC 
(A); NAc (B); WMF (C) 
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Figure 5.3: Scatter plots and a line of fit (red) showing the relationship between average behavioral 
outcomes and the location of a stimulated voxel along a particular axis: M-L (left), D-V(middle), A-P 
(right). Results are shown for vmPFC (A), NAc (B), and WMF (C). 
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Figure 5.4: Surfaces: IL (purple), PrL (gray), sum of all activated regions in all animals (pink). 
According to this figure, there is a strong trend that indicates high immobility (and therefore high 
depression) in the dorsal/posterior region versus low immobility in the anterior region of the activated 
surface in the VMPFC. 
Axes: +blue = anterior; +red = lateral; +green = dorsal 
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Figure 5.5: Surfaces: NAc core (light blue) and shell (dark blue), sum of all activated regions in all animals 
(pink). 
According to this figure, there is a strong trend that indicates high immobility (and therefore high 
depression) in the lateral region versus low immobility in the medial region of the activated surface in the 
NAc 
Axes: +blue = anterior; +red = lateral; +green = dorsal 
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Figure 5.6: Surfaces: White matter ranging from 2.2 mm - 2.7 mm in the A-P axis on Paxinos (light-gray), 
sum of all activated regions in all animals (pink). 
According to this figure, there is a strong trend that indicates high immobility (and therefore high 
depression) in the ventral region versus low immobility in the dorsal region in the activated WMF 
Axes: +blue = anterior; +red = lateral; +green = dorsal 
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IV. Discussion 
Neuron response to DBS is highly dependent on location of electrode, stimulation 
parameters, and synaptic influences (McIntyre et al., 2004). The goal of our study was to 
evaluate the effect of stimulation location in three targets using DBS for depression in a 
rodent model. Our hypothesis was that improvement in depression as measured by 
reduction in immobility depends on the target and the position of the active electrode 
within a target.  
Several studies use neuroimaging and computational models to explore the effect 
of electrode location within a stimulation target on behavioral outcomes. However, to our 
knowledge, this is the first time probabilistic analysis has been applied to animal models. 
Our previous study investigating the role of stimulation parameters in EpCS concluded 
that an anterior/lateral placement of electrodes within the L-DLPFC contributed to higher 
improvement (Pathak et al., 2012). In a model (McIntyre et al., 2004) examining the 
cellular effects of DBS, McIntyre et al. showed that neuron response was contingent on 
the position and orientation of the axon relative to the electrode. The initial hypothesis 
regarding DBS was that it served as a “reversible lesion” (Benabid et al., 1991; 
Benazzouz et al., 1995; Holtzheimer & Mayberg, 2011), but evolving research points 
toward a more complex mechanism including both excitation and inhibition of neuronal 
elements (cell bodies and axons) within the field of stimulation (Holtzheimer & Mayberg, 
2011; Iremonger et al., 2006; McIntyre et al., 2004). Observed results from the current 
study further this notion of complexity by demonstrating the significance of within-target 
stimulation, which is likely inducing response by activating a complex pattern of 
neuronal elements. 
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Specifically, we advanced previous findings by evaluating the role of stimulating 
individual voxels in contributing to an antidepressive-like response in DBS. We 
investigated the VMPFC, which is equivalent to the human sACC, WMF of the frontal 
regions, and the NAc (Gabbott et al., 2003; Hamani et al., 2014; Hamani, Diwan, 
Macedo, et al., 2010; Takagishi & Chiba, 1991). 
VMPFC is pivotal in the pathophysiology of rodent depression. The 
VMPFCdorsal raphe nucleus (DRN) pathway was deemed key in inducing an 
antidepressive response (Artigas, 2014; Warden et al., 2012). Furthermore, repeated DBS 
at the target increased excitatory inputs to 5HT neurons and reversed neuroplastic 
changes that formed during the development of a depressed phenotype (Veerakumar et 
al., 2013). In the VMPFC, we found that an antidepressive response was related to 
stimulation in the ventral/anterior region. Because the rodent VMPFC has a multitude of 
projections to distinct cortical and subcortical sites, the stimulation location will have a 
specific effect on response (Artigas, 2014). Location in the D-V axis had the greatest 
influence on behavioral response. Both IL and the PrL nuclei are separated along this 
axis.  Earlier studies have shown distinct amygdalar and insular projections to these 
nuclei (Hoover & Vertes, 2007; McDonald et al., 1996; Vertes, 2004). The efferents from 
these VMPFC nuclei are distinctive as well and consistent with their respective functions 
(McDonald et al., 1996; Vertes, 2004). IL is typically regarded as the visceromotor center 
and is involved with the inhibition of subcortical structures during emotional processing. 
It projects widely to the amygdala, including superficial nuclei, basolateral nuclei, and 
the central nucleus. In contrast, the PrL participates primarily in cognitive processes with 
virtually no projections to the superficial nuclei of the amygdala (Hoover & Vertes, 
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2007). One study characterizing emotional conflict showed that the dorsal and ventral 
regions of the ACC and medial PFC are functionally different (Etkin et al., 2011) Both 
dorsal ACC and mPFC are involved in appraisal and experience of emotional memories, 
whereas the ventral ACC and mPFC contribute to inhibition and regulation by mediating 
between dorsal areas and amygdala since there are no direct connections between these 
regions.  
sACC, the human correlate to rodent VMPFC, has also shown reciprocal 
connections with the amygdala (Johansen-Berg et al., 2008). Additionally, a clinical DBS 
trial (Riva-Posse et al., 2014) showed the functional variability of sACC. In order to 
achieve clinical response, specific white matter tracts (forceps minor, cingulum bundles, 
uncinate fasciculus) needed to be recruited. These fiber tracts connect remote areas of the 
brain with the sACC and modulate the depressive circuit as a whole. One of those regions 
is the NAc, which connects to the sACC through the medial branch of the uncinate 
fasciculus. 
The NAc plays a central role in reward circuitry. It is investigated as a DBS target 
because of the prominent anhedonic symptoms in depression. According to a previous 
clinical study, DBS at NAc decreased metabolism in sACC and amygdala, both of which 
are hypermetabolic in depression. In addition, an antianhedonic effect was observed in 
responders (Bewernick et al., 2010). However, in a recent rTMS study, stimulating at the 
L-DLPFC did not result in altered connectivity with NAc, implying that although it may 
alleviate symptoms, its role in reversing MDD is not principal (see Chapter 4). In our 
analysis, the antidepressive response was related to stimulation in the medial region of 
NAc. A study (Usuda et al., 1998) using biotinylated dextran amine anterograde tracer 
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demonstrated the differential connectivity patterns of the dorso-medial and ventro-lateral 
regions of the NAc core. Although both regions project to nodes of the reward circuit, 
particularly the ventral pallidum, targets of the dorso-medial region also include 
substantia nigra reticulata and the lateral hypothalamus whereas those of the ventro-
lateral region include globus pallidus and substantia nigra compacta. These efferents 
imply that dorso-medial NAc contributes to motor regulation and ventro-lateral NAc 
supplements motivational processes. Our results exhibit this characteristic in the M-L 
axis. Stimulation in the medial region of the core correlated with low immobility/high 
improvement in behavioral response.  
Stimulation in this target also corresponded to the best antidepressive response 
when compared to the other DBS targets. One reason for that could be the task (FST) 
used to assess antidepression in rodents is more sensitive to physical behavior than mood. 
Anhedonia is defined as the lack of desire to participate in an activity and DBS at this 
region is effectively reversing this symptom as measured with a decrease in immobility. 
The results from analyzing this site in the context of previous findings suggest 
consideration of MDD as a heterogeneous disorder for which it might be more beneficial 
to customize treatment targeted toward a specific symptom instead of a one-size-fits-all 
approach.  
The role of fiber tracts in modulating the depressive circuit has been established 
(Gutman et al., 2009; Li et al., 2007; Riva-Posse et al., 2014). However, white matter 
connectivity has been shown to be rather complex. A tractography study examining the 
projections of ALIC found that the pattern of connectivity was spatially dependent in a 
multifarious manner with afferents and efferents of the thalamus (Gutman et al., 2009). 
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Rats lack a developed ALIC, and therefore the largest white matter structure, forceps 
minor, was chosen. Also, this white matter structure contains commissural and projection 
fibers (Hamani & Nóbrega, 2010; Hamani et al., 2014). The response at this site was 
quite segregated in the D-V axis with antidepressive-like behavior correlating to 
stimulation in the dorsal region, possibly because these fibers have specific projections 
and the response is a result of modulating nodes at the end of them. Fibers passing 
dorsally are likely connecting regions that are more significantly involved in the 
pathology of depression.  
These results lead to two plausible theories: 1) the activated sub-region activity 
within a target is responsible for improved behavioral response or 2) the activated sub-
region projects differentially to nodes of the depressive circuit responsible for behavioral 
improvement. The latter theory has become increasingly relevant as neuroimaging studies 
provide evidence for changes in connectivity and synaptic plasticity and mandate we 
redefine neurological conditions as network-level disorders. Observations from this study 
offer a possible factor in characterizing the variability of response in an extremely 
heterogeneous condition. 
Nevertheless, there are some limitations to this study. First of all, we are 
investigating an animal model, which is a great physiological analog, but does not quite 
allow the assessment of mood. Also, these animals were implanted bilaterally, but 
laterality was not taken into account during the analysis. Since there was only one 
immobility score per animal, it was difficult to discern how each hemisphere contributed 
to the outcome. In addition, all electrode locations were mapped onto the Paxinos atlas, 
disregarding the inherent neuroanatomical variability between subjects. 
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V. Conclusion 
Despite the limitations, the results of this study add value to current research 
surrounding DBS for depression. First, this study facilitates understanding of each 
individual target and sets the foundation for future studies to investigate the effect of 
stimulation at a particular target to improve a specific symptom. Second, it highlights the 
heterogeneity of each brain region and further emphasizes the significance of location in 
predicting the antidepressive outcome. Overall, these findings can form the foundation 
for future studies that should incorporate details of anatomical and functional 
connectivity to validate the subregion differences and optimize DBS therapy for MDD.  
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CHAPTER 6: CLINICAL IMPACT 
 
 
 
Practical application of our research in clinical practice is the ultimate motivation 
for biomedical engineers to delve into the complexity of neuromodulation therapies. 
Ideally, physicians would prefer an in-office device that could help diagnose, navigate, 
and noninvasively stimulate the brain to treat MDD. Such a device can be implemented 
in a few years with integrative studies and incorporation of advanced technologies, but a 
more immediate and tangible problem faces the clinical community.   
Currently, there are no clinically acceptable methods to predict treatment 
response. The methods described in this dissertation are certainly a step in that direction. 
First of all, the results indicate that functional neuroimaging can be used as an indirect 
biomarker of response. Additionally, the correlative analysis of stimulation parameters, 
neuroimaging outcomes, and behavioral scores is a bridge to link the physiological basis 
of MDD to behavioral relevance.   
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CHAPTER 7: CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
 
MDD is a circuit-based disorder and neuromodulation therapies should be 
designed to interrogate the whole circuit. The findings of this dissertation are a trend in 
improving the predictive power of future studies in neuromodulation by combining 
neuroimaging with computational tools. We have shown that there are several successful 
ways to modulate the depressive circuit; each modality has a specific set of parameters 
that will help achieve a robust clinical response. It is apparent that neuromodulation 
effects are location dependent. However, these findings encourage us to expand our 
definition of location from mere anatomical coordinates to essential functional pathways. 
Both studies targeting the L-DLPFC showed that a wide range of neural elements needed 
to be recruited in order to observe a clinical response. Subregions of individual targets 
also present differential outcomes to stimulation. Additionally, we demonstrated that 
MDD patients can be broadly characterized as slow or fast responders and the type of 
neuromodulation prescribed should take into account an individual’s unique time-
constant for improvement. DBS for depression is popular, but its invasive nature makes 
the stakes quite high. We have established that rTMS can be used to interrogate and 
manipulate the circuit implicated in DBS therapy.  
Future studies need to account for variables that were not explored in this 
dissertation. First, the durability of response should be studied beyond 2 weeks for rTMS 
therapy. A cost-benefit analysis of noninvasive short-term therapy versus invasive 
chronic stimulation can further help determine if rTMS should be used as a tool for 
surgical planning or as a therapeutic option. Also, anatomical connectivity can validate 
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interpretations of the functional connectivity analysis and the differential behavior of 
DBS at several targets. Lastly, this study explored only the longitudinal effects of 
neuromodulation. A deeper understanding of the mechanisms of action for 
neuromodulation can be possible only by also investigating the acute effects of 
stimulation with simultaneous EEG and rTMS.  
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APPENDIX 
 
 
 
Transcranial Magnetic Stimulation 
 
Bio-Savart Law (Eq 1) 
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Source Imaging 
Linear inverse operator (Eq 3) 
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Welch Algorithm (PSD) 
Signal is split into overlapping segments and a periodogram is computed using discrete 
fourier transform (DFT) 
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